• View Full Article
• View Full Article PDF
• Download Citation
• Add to Papers

– Randomized controlled trial – Resuscitation – Glucose – Hypothermia – Mortality – Enolase

References

1. Herlitz J, Castren M, Friberg H, Nolan JP, Skrifvars MB, Sunde K, Steen P (2006) Post resuscitation care: what are the therapeutic alternatives and what do we know? Resuscitation 69:15–22
   
   • 
   • 
2. Nolan JP, Deakin CD, Soar J, Böttiger BW, Smith G (2005) European Resuscitation Council Guidelines for Resuscitation 2005. Section 4. Adult advanced life support. Resuscitation 67:S39–S86
   
   • 
   • 
3. Langhelle A, Tyvold S, Lexow K, Hapnes S, Sunde K, Steen P (2003) In-hospital factors associated with improved outcome after out-of-hospital cardiac arrest. A comparison between four regions in Norway. Resuscitation 56:247–263
   
   • 
   • 
4. Skrifvars MB, Pettilä V, Rosenberg PH, Castren M (2003) A multiple logistic regression analysis of in-hospital factors related to survival at six months in patients resuscitated from out-of-hospital ventricular fibrillation. Resuscitation 59:319–328
   
   • 
   • 
5. HACA Study Group (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549–556
   
   • 
6. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K (2002) Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346:557–563
   
   • 
   • 
7. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW (2003) Therapeutic hypothermia after cardiac arrest. An advisory statement by the advanced life support task force of the international liaison committee on resuscitation. Circulation 108:118–121
   
   • 
   • 
8. Van den Berghe G, Wouters PJ, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlaesselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367
   
   • 
   • 
9. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461
   
   • 
   • 
10. Meynaar I, Oudemans-van Straaten H, van der Wetering J, Verlooy P, Slaats E, Bosman R, van der Spoel J, Zandstra D (2003) Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study. Intensive Care Med 29:189–195
    
    • 
11. Schoerkhuber W, Kittler H, Sterz F, Behringer W, Holzer M, Frossard M, Spitzauer S, Laggner A (1999) Time course of serum neuron-specific enolase: a predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 30:1598–1603
    
    • 
12. Rosén H, Stibrant Sunnerhagen K, Herlitz J, Blomstrand C, Rosengren L (2001) Serum level of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 49:183–191
    
    • 
    • 
13. Tiainen M, Roine RO, Pettilä V, Takkunen O (2003) Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke 34:2881–2886
    
    • 
    • 
14. De Latorre F, Nolan JP, Robertson C, Chamberlain D, Baskett P (2001) European Resuscitation Council guidelines 2000 for adult advanced life support. Resuscitation 48:211–221
    
    • 
    • 
15. Longstreth W, Inui T (1984) High blood glucose level on hospital admission and poor neurological recovery after cardiac arrest. Ann Neurol 15:59–63
    
    • 
    • 
16. Müllner M, Sterz F, Binder M, Schreiber W, Deimel A, Laggner AN (1997) Blood glucose concentration after cardiopulmonary resuscitation influences functional neurological recovery in human cardiac arrest survivors. J Cereb Blood Flow Metab 17:430–436
    
    • 
    • 
17. Preiser J-C, Devos P (2007) Steps for the implementation and validation of tight glucose control. Intensive Care Med 33:570–571
    
    • 
    • View ICM abstract
18. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M (2006) Intensive insulin therapy in mixed medical/surgical intensive care units. Benefit versus harm. Diabetes 55:3151–3159
    
    • 
    • 
19. Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041–2047
    
    • 
    • 
20. Vriesendorp T, DeVries J, van Santen S, Moeniralam H, de Jonge E, Roos Y, Schultz M, Rosendaal F, Hoekstra J (2006) Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med 34:2714–2718
    
    • 
    • 
21. Brunkhorst FM, Kuhnt E, Engel C, Meier-Hellmann A, Ragaller M, Quintel M et al. (2005) Intensive insulin therapy in patient with severe sepsis and septic shock is associated with an increased rate of hypoglycemia—results from a randomized multicenter study (VISEP). Infection 33:19–20
22. Brunkhorst FM, Reinhart K (2007) Intensive insulin therapy in the ICU: benefit versus harm? Intensive Care Med 33:1302
    
    • 
    • View ICM abstract
23. Kanji S, Singh A, Tierney M, Meggison H, McIntyre L, Hebert PC (2004) Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 30:804–810
    
    • 
    • View ICM abstract
24. Meynaar IA, Dawson L, Tangkau PL, Salm EF, Rijks L (2007) Introduction and evaluation of a computerised insulin protocol. Intensive Care Med 33:591–596
    
    • 
    • View ICM abstract
25. Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP, Smedsrud C, Draegni T, Steen PA (2007) Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation 73:29–39
    
    • 
    •